Abstract:BACKGROUND & OBJECTIVE:In recent years, the neoadjuvant chemotherapy for cervical cancer has evoked more and more attention and has been used widely. But the chemosensitivity of individuals to various antitumor drugs is different. This study was to investigate the chemosensitivity of cervical cancer cells to antitumor drugs using in vitro MTT assay chemosensitivity test. METHODS:The sensitivity of fresh human cervical cancer cells from 32 patients to 9 cytotoxic drugs was tested using in vitro MTT assay. RESULTS:The cytotoxic activities of the 9 drugs for cervical cancer were in sequence from high to low as follows: liposomal paclitaxel, taxol, carboplatin (CBP), ifosfamide (IFO), etoposide (VP-16), 5-fluorouracil (5-FU), cisplatin (DDP), bleomycin (BLM), and cyclophosphamide (CTX). Generally, cervical cancer cells were more sensitive to paclitaxel, taxol, and CBP than to other drugs (P<0.05) with inhibition rates of 56.56%, 55.66%, and 46.81%, respectively. Stage Ib1 cervical cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 58.71%, 53.00%, and 49.25%, respectively; stage Ib2 cervical cancer cells were more sensitive to paclitaxel and taxol than to other drugs with inhibition rates of 65.26% and 50.06%. Both moderately and poorly differentiated squamous cell cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 52.01%, 49.21%, and 40.02% for the former, and 60.02%, 61.16%, and 48.75% for the latter. CONCLUSIONS:MTT assay, a sensitive and widely used chemosensitivity testing method, is helpful in sensitive drug screening and neoadjuvant chemotherapy regimen selection for cervical cancer. Cervical cancer cells are more sensitive to paclitaxel, taxol, and CBP than to other tested drugs in this study.

PREDICTION OF SENSITIVITY ON HEPATOMA CHEMOIMMUNOTHERAPY USING MTT ASSAY

Research and Exploratory of Chemotherapy Drugs Sensitivity Tests in Liver Cancer

Predictive Chemotherapy of Advanced Breast Cancer Directed by MTT Assay in Vitro

Cell Factor and Anti-tumor Medicine Body in Conjunction with Sensitivity Experiment of Repress Liver Cancer SMMC-7221 cell Outside

Study on Chemosensitivity of Peripheral Blood Lymphocytes and Tumor Cells of Tumor Patients in Vitro

Application of in Vitro ATP-TCA and FCM in Chemotherapy of Primary Liver Cancer

P1.03-046 A Retrospective Analysis of Correlation Between Cytokines in TME and Therapeutic Effect of Advanced Lung Cancer Chemotherapy in China

Experimental Study on the Anti - Cancer Drugs' Sensitivity in the Colormetric Assay of Cancer Cells with MTT and Its Effective Factors

Application of the Improved MTT Assay in Predicting the Intrinsic Drug Resistance of Liver Cancer

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

Distinct Immune Signatures in Peripheral Blood Predict Chemosensitivity in Intrahepatic Cholangiocarcinoma Patients

APOPTOSIS AND DRUG SENSITITY TEST OF LUNG CANCER CELL

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

[Progress of Individualized Chemotherapy Guided by Chemosensitivity Test].

MTT measuring drug sensitivity of cancer cells and its relationship with clinical prescription

Anticancer Drug Sensitivity Test of Malignant Plcural and Ascitic Fluid with MTT Colorimetric Method

Study on the Sensitivity of Combined Chemotherapy Regimens for AML in Vitro and in Vivo

Drug Susceptibility Test in Carcinoma of Gallbladder and Cholangiocarcinoma

Sensitivity of Different Chemotherapy Drugs on the Liver Cancer Ceil Lines under Environment of Intervention Therapy

[Relationship Between Sensitivity of Tumor Cells to Chemotherapeutic Agent in Vivo and in Vitro: Experiment with Mouse Lymphoma Cells].

Study on the chemosensitivity test with TECIA in vitro for the choice of individualized chemotherapy of lung cancer